Health
Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer – News-Medical.Net
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis…
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In a new study in TheJournal of Molecular Diagnosis, published by Elsevier, investigators provide for the first time a complete overview of biomarker testing, spanning multiple treatment lines, in a single cohort of patients.
Using exploratory data analysis and process-mining techniques in a real-world…
-
Noosa News23 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Noosa News24 hours agoOats free of gluten contaminants can’t be labelled gluten-free
-
Noosa News23 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
Business22 hours ago3 steps to take to build a $1,000 monthly passive income